Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
US5576353A · kind A · utility
48Cited by
5References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 1995 |
| Grant date | Nov 19, 1996 |
| Priority date | — |
| Expiry date | Jun 2, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
R(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.